Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine.

Source:http://linkedlifedata.com/resource/pubmed/id/19584709

Download in:

View as

General Info

PMID
19584709